1.Detection of Microcalcifications in Digital Mammograms Using Foveal Method.
Whi Vin OH ; Kwanggi KIM ; Young Jae KIM ; Hansung KANG ; Jungsil RO ; Wookyung MOON
Journal of Korean Society of Medical Informatics 2009;15(1):165-172
OBJECTIVE: Breast cancer represents themost frequently diagnosed cancer in women. In order to reduce mortality, early detection of breast cancer is important, because diagnosis is more likely to be successful in the early stages of the disease. On the average, the reader's sensitivity can be increased by 10%with the assistance of computer-aided diagnosis (CAD) system. This paper presents a CAD system for the automatic detection of clustered micro-calcifications in digitized mammograms. METHODS: The proposed system consists of three main steps. First, breast region is segmented from original mammogram using contrast property of grey level co-occurrence matrix(GLCM). Second, potential micro-calcification pixels in the mammograms are detected by foveal method. Third, in order to reduce false-positive rate, individual micro-calcifications are detected by a set of 8 features extracted from the potential individual micro-calcification objects. RESULTS: In the result, Specificity and sensitivity are used to evaluate the detection performance of micro-calcifications.(sensitivity : 93.1%, specificity : 87.5%). CONCLUSION: This study could be a useful method for diagnosis of breast cancer as a CAD system.
Breast
;
Breast Neoplasms
;
Diagnosis
;
Female
;
Humans
;
Mortality
;
Sensitivity and Specificity
2.Evaluation on the effect of intervention regarding breast self-examination for decreasing breast cancer mortality.
Dao-li GAO ; Yong-wei HU ; Wen-wan WANG ; Fan-liang CHEN ; Lei-da PAN ; Ya YUAN ; Ling-di YU ; Feng QIAN
Chinese Journal of Epidemiology 2006;27(11):985-990
OBJECTIVEA randomized trial of breast self-examination (BSE) Program was carried out to evaluate whether the intensive BSE could reduce the number of deaths among women from breast cancer.
METHODSThis study was a randomized controlled trial (RCT). A total of 266 064 women (age of 30 to 64 years) associated with 519 textile factories in Shanghai had been randomly assigned to a BSE group (132 979 women) or a control group (133 085 women) since 1989. Initial instruction in BSE group would include demonstration of proper palpation techniques and was followed by 2 reinforcement sessions during the subsequent 4 years including video shows, BSE instruction sessions and BSE practice under medical supervision. These activities were continued for 5 years. Attendance at all events was recorded. The cohort was followed through July 2000 for development of breast diseases, and the breast cancer cases were followed through 2001 for vital status. Data analysis methods used would include Kaplan-Meier plots, log-rank test and Cox modeling.
RESULTSAmong women under instruction, 864 breast cancers detected and 133 breast cancer deaths occurred while 896 breast cancers were detected and 130 deaths recorded in the control group. The tumor size (P = 0.07), TNM stage (P = 0.39) and cumulative breast cancer mortality rate (P = 0.72) were not significantly different between the 2 groups. However, more and smaller fibroadenomas were detected in the instruction group than in the control group (P< 0.01).
CONCLUSIONIntensive instruction in BSE did not seem to have reduced the mortality rate of breast cancer, but more and smaller benign breast lumps could be detected.
Adult ; Breast Diseases ; diagnosis ; Breast Neoplasms ; diagnosis ; mortality ; Breast Self-Examination ; China ; Female ; Humans ; Middle Aged ; Patient Education as Topic
3.Metastasis-Free Interval Is Closely Related to Tumor Characteristics and Has Prognostic Value in Breast Cancer Patients with Distant Relapse.
Hee Jun KIM ; Sung Gwe AHN ; Hak Min LEE ; Jong Tae PARK ; Kyunghwa HAN ; Seung Ah LEE ; Joon JEONG
Journal of Breast Cancer 2015;18(4):371-377
PURPOSE: We investigated the relationships between metastasis-free interval (MFI) and tumor characteristics, and assessed the prognostic value of MFI for survival after metastasis in patients with metastatic breast cancer. Furthermore, we compared MFI among the subtypes. METHODS: We identified 335 patients with postoperative tumor recurrence at distant site(s). All patients underwent curative resection and had a MFI of at least 6 months. MFI was categorized as short (<2 years), intermediate (> or =2 years and <5 years), or long (> or =5 years). Overall survival after metastasis (OSM) was estimated. RESULTS: Patients with a shorter MFI were younger, more likely to have initial metastasis to visceral organs, and had a larger tumor with a higher stage and grade as well as a higher rate of nodal involvement at initial diagnosis. Among 136 patients with known disease subtypes, shorter MFI was associated with the triple-negative subtype while longer MFI was associated with the hormone receptor-positive/human epidermal growth factor receptor 2 negative subtype. Mortality after metastasis declined sharply with increasing MFI up to approximately 2 years, and continued gradually declining between 2 and 5 years. An MFI longer than 5 years did not add any survival benefit. MFI was a significant prognostic factor for OSM independent of nodal status, stage, metastatic site, and hormone receptor status of the metastasized cancer. CONCLUSION: MFI is closely related to biological characteristics of both primary tumors and their metastases, and has a prognostic value for survival after metastasis. We therefore suggest investigation into treatments targeting improvement of MFI as a potential novel strategy.
Breast Neoplasms*
;
Breast*
;
Diagnosis
;
Humans
;
Mortality
;
Neoplasm Metastasis
;
Population Characteristics
;
Receptor, Epidermal Growth Factor
;
Recurrence*
4.Interval Breast Cancers: Comparisons with Screen Detected Cancers.
Jun Young KIM ; Back Hyun CHO ; Min Hee HUR ; Sung Soo KANG ; Jee Hyun LEE ; Sung Kong LEE ; Byung Jae CHO ; Kyung Sang LEE ; Hae Kyung LEE
Journal of the Korean Surgical Society 2002;63(6):458-461
PURPOSE: Although the screening with a mammography has been shown to reduce breast cancer mortality, it has limitations relating to its sensitivity and efficacy. Interval cancers are those that become symptomatic, and are detected between screening examinations. The success of a screening program in reducing the rate of mortality due to breast cancer relies on keeping the number of interval cancers at a minimum. This study was performed to review the mammographic features of interval cancers, and to compare their clinicopathological factors with those cancers detected by screening. METHODS: Of the 881 women who had operations for breast cancer performed between 1995 and 1999, we retrospectively analyzed the medical records and mammograms of 57 who received at least a mammogram before the diagnosis of their breast cancer. These patients were divided into an interval cancer group, who had symptoms, and a screen detected cancer group, who had not. The factors compared included the clinical, radiographic, histopathological, and immunohistochemical features. RESULTS: Interval cancers were more likely to have masses, than microcalcifications, in their mammographic features, and were more likely to be invasive and at a higher stage according to their histopathological features. The false negative rate was 48% for the screen detected cancers, and 35% for the interval cancers (P=0.414). HRT users had the higher false negative rate of 51.6% than the 26.9% for the nonuser (P=0.103). CONCLUSION: The interval cancers were found to be different from the screen detected cancers in terms of their radiological and pathological features. The standardization of screen interval, and additional magnification mammography, or ultrasonography may contribute to reduce false negative rates of mammography.
Breast Neoplasms
;
Breast*
;
Diagnosis
;
Female
;
Humans
;
Mammography
;
Mass Screening
;
Medical Records
;
Morinda
;
Mortality
;
Retrospective Studies
;
Ultrasonography
5.Fibromyalgia syndrome after comprehensive treatment of breast cancer: a case report.
Xia DING ; Yan LI ; Yiyi CUI ; Yingying SHEN ; Jianzhong GU ; Yong GUO
Journal of Zhejiang University. Medical sciences 2016;45(4):429-431
Fibromyalgia syndrome after comprehensive treatment of breast cancer is rare and seldom reported. Here we present a case of a 50-year-old female patient,who was admitted to the hospital because of generalized fibromyalgia for 3 months and brain metastasis after the right breast carcinoma surgery for 1 month, and the clinical diagnosis was brain metastasis from breast carcinoma combined with fibromyalgia syndrome. The fibromyalgia were relieved with proper symptomatic treatment but the patient eventually died of tumor progression.
Brain Neoplasms
;
mortality
;
secondary
;
Breast Neoplasms
;
complications
;
mortality
;
therapy
;
Carcinoma
;
mortality
;
therapy
;
Female
;
Fibromyalgia
;
diagnosis
;
etiology
;
therapy
;
Humans
;
Middle Aged
6.Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers.
Janghee LEE ; Seho PARK ; Sanghwa KIM ; Jeeye KIM ; Jegyu RYU ; Hyung Seok PARK ; Seung Il KIM ; Byeong Woo PARK
Yonsei Medical Journal 2015;56(5):1213-1220
PURPOSE: Newly developed extra-mammary multiple primary cancers (MPCs) are an issue of concern when considering the management of breast cancer survivors. This study aimed to investigate the prevalence of MPCs and to evaluate the implications of MPCs on the survival of breast cancer patients. MATERIALS AND METHODS: A total of 8204 patients who underwent surgery at Severance Hospital between 1990 and 2012 were retrospectively selected. Clinicopathologic features and survival over follow-up periods of < or =5 and >5 years were investigated using univariate and multivariate analyses. RESULTS: During a mean follow-up of 67.3 months, 962 MPCs in 858 patients (10.5%) were detected. Synchronous and metachronous MPCs were identified in 23.8% and 79.0% of patients, respectively. Thyroid cancer was the most prevalent, and the second most common was gynecologic cancer. At < or =5 years, patients with MPCs were older and demonstrated significantly worse survival despite a higher proportion of patients with lower-stage MPCs. Nevertheless, an increased risk of death in patients with MPCs did not reach statistical significance at >5 years. The causes of death in many of the patients with MPCs were not related to breast cancer. Stage-matched analysis revealed that the implications of MPCs on survival were more evident in the early stages of breast disease. CONCLUSION: Breast cancer patients with MPCs showed worse survival, especially when early-stage disease was identified. Therefore, it is necessary to follow screening programs in breast cancer survivors and to establish guidelines for improving prognosis and quality of life.
Adult
;
Aged
;
Breast/pathology
;
Breast Neoplasms/diagnosis/*mortality
;
Female
;
Humans
;
Middle Aged
;
Multivariate Analysis
;
Neoplasm Metastasis
;
Neoplasm Staging
;
Neoplasms, Multiple Primary/diagnosis/*mortality
;
Neoplasms, Second Primary/diagnosis/*mortality
;
Prognosis
;
*Quality of Life
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Survival Analysis
7.Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen
Soo Yeon BAEK ; Ji Yeong KWON ; Young Joo LEE ; Sung chan GWARK ; Sae Byul LEE ; Jisun KIM ; Il Yong CHUNG ; Beom Seok KO ; Hee Jeong KIM ; Sung Bae KIM ; Seung Do AHN ; Gyungyub GONG ; Byung Ho SON ; Sei Hyun AHN ; Jong Won LEE
Journal of Breast Cancer 2019;22(3):387-398
PURPOSE: The extension of endocrine therapy beyond 5 years for recurrence-free survivors of breast cancer improves survival; however, the issue on how to clinically identify appropriate candidates remains controversial. This study aimed to identify prognostic factors for breast-cancer-specific mortality in patients who have had 5 years of tamoxifen treatment and categorize subgroups based on the risk of death using combinations of these prognostic factors to assist in the clinical decision to perform further endocrine therapy. METHODS: In total, 3,158 patients with breast cancer were enrolled. Breast cancer-specific survival rates after 5 years of tamoxifen treatment were calculated, and associated prognostic factors were analyzed using a Cox proportional-hazards model. RESULTS: An age extreme at diagnosis (i.e., < 40 or ≥ 60 years), tumor size > 2 cm, and positive lymphovascular invasion were robust independent prognostic factors for late breast cancer-specific death in tamoxifen-treated patients (hazard ratio [HR] = 2.162, 1.739, and 1.993; p = 0.001, 0.047, and 0.011, respectively). Lymph node metastasis and progesterone receptor negativity had borderline significance in this regard (HR = 1.741 and 1.638, p = 0.099 and 0.061). The study patients were classified into four groups according to the number of prognostic indicators, i.e., low, intermediate, high, and extremely high risk. The additional 5- and 10-year cumulative risks of breast cancer-specific death were 0.8% and 1.5% in the low-risk group, 0.9% and 3.9% in the intermediate-risk group, 1.3% and 7.3% in the high-risk group, and 4.8% and 13.8% in the extremely high-risk group, respectively. CONCLUSION: This new risk stratification system for late mortality in breast cancer can be used to identify the right candidates for extended endocrine therapy after 5 years of tamoxifen treatment.
Breast Neoplasms
;
Breast
;
Diagnosis
;
Humans
;
Lymph Nodes
;
Mortality
;
Neoplasm Metastasis
;
Prognosis
;
Receptors, Progesterone
;
Survival Rate
;
Survivors
;
Tamoxifen
8.Diagnosis and Risk Factors of Advantage Cancers in Ethiopia
Samrawit SOLOMON ; Wudeneh MULUGETA
Journal of Cancer Prevention 2019;24(3):163-172
BACKGROUND: Cancer is one of the leading causes of morbidity and mortality worldwide. Yet, limited is known about patterns of cancer and risk factors for advanced stage cancers in Ethiopia. METHODS: A cross-sectional study was conducted on 919 patients with biopsy-confirmed cancers at Tikur Anbessa Hospital in Ethiopia, 2010 to 2014. Pearson chi-square test, t-test, analysis of variance and multivariate logistic regression analyses were performed. RESULTS: The majority of the patients were females (72.4%). The commonest malignancies among males were bone and soft tissue (16.5%), colorectal (12.2%), and esophageal (9.1%). Among females, the most common cancers were cervical (39.7%), breast (18.3%), and ovarian (7.1%); of these, 41.7%, 59.0%, and 42.6% were diagnosed at advanced stages, respectively. Females had more advanced stage cancers at diagnosis than males (37.6% vs. 24.8%, P < 0.01). Among males, 46.7% of prostate and 29.0% of colorectal cancers were in advanced stages at the time of diagnosis. Delay in presentation from onset of symptoms was associated with advanced cancer among females (OR = 3.21; 95% CI = 1.69–6.10). Prostate cancer among males (OR = 5.22; 95% CI = 1.26–21.60) and breast cancer among females (OR = 1.93; 95% CI = 1.23–3.03) were more likely to be diagnosed at advanced stages. CONCLUSIONS: Cancers with effective screening tests are common in Ethiopia and significant proportions of these were diagnosed at advanced stages, typically several months after onset of symptoms. Timely access to preventive care along with effective educational and screening strategies is needed in Ethiopia for early detection and treatment of common malignancies, such as cervical, breast and colorectal cancers.
Breast
;
Breast Neoplasms
;
Colorectal Neoplasms
;
Cross-Sectional Studies
;
Diagnosis
;
Ethiopia
;
Female
;
Humans
;
Logistic Models
;
Male
;
Mass Screening
;
Mortality
;
Neoplasm Staging
;
Prostate
;
Prostatic Neoplasms
;
Risk Factors
9.The Result of First Year Screening for Breast Cancer in National medical Center.
Jong Heung KIM ; Yeong Kyu CHA ; Chong Hyun YOON ; Ze Hong WOO ; Kyong Woo CHOI
Journal of the Korean Surgical Society 1997;53(5):617-621
Breast cancer is a major public health problem. 1 woman in 8 will have breast cancer develop during her lifetime in America. As in the United States, long-term increases in the incidence of breast cancer are being observed worldwide. The high incidence of breast cancer in the female population is provide the rationale for screening. The principal purpose of screening for breast cancer is to reduce mortality from the disease through early diagnosis and treatment. It is demonstrate that mortality from breast cancer can be reduced as much as 30% in a screened population. Thus the authors tried screening for breast cancer by mammography with education in breast self examination and classified mammographic parenchymal pattern of the breast in the National Medical Center. The results obtained were summarized briefly as follows:1) Between 1995-5 and 1995-7, 329 women over aged 35 in National Medical Center were invited for screening by mammography with education in breast self examination and mammographic parenchymal pattern of the breast. 2) 294(89.3 percentage) women in 329 were attended for screening and mammographic parenchymal pattern of the breast. 3) A group of 16 women(4.9 percentage) was called for further assessment. 4) 5 women(1.7 percentage) had suspicious lesions and proceeded to surgical biopsy; 4 lesions proved fibrocystic disease and 1 lesion proved fat necrosis and dystrophic calcification. 5) The mammographic parenchymal pattern of the breast showed the number of women according to classification: 20%, 23%, 50%, 7% for N1, P1, P2, DY type, respectively. 6) The malignant lesion was not detect. The results are not statistically significant. But periodic mammography screening of asymptomatic women shows that a satisfactory cancer detection can be achievable. Follow-up of women over aged 35 in the National Medical Center is continuing.
Americas
;
Biopsy
;
Breast Neoplasms*
;
Breast Self-Examination
;
Breast*
;
Classification
;
Early Diagnosis
;
Education
;
Fat Necrosis
;
Female
;
Follow-Up Studies
;
Humans
;
Incidence
;
Mammography
;
Mass Screening*
;
Mortality
;
Public Health
;
United States
10.Factors Affecting Breast Self-examination Behavior Among Female Healthcare Workers in Iran: The Role of Social Support Theory
Saeed BASHIRIAN ; Majid BARATI ; Leila Moaddab SHOAR ; Younes MOHAMMADI ; Mitra DOGONCHI
Korean Journal of Preventive Medicine 2019;52(4):224-233
OBJECTIVES: In women, breast cancer is the most common cancer and the leading cause of cancer death. Screening tests are the basis for early diagnosis. In Iranian women, the mortality rate of breast cancer is high due to insufficient screening examinations and delayed visits for care. Therefore, this study aimed to determine the factors affecting breast self-examinations among Iranian women employed in medical careers. METHODS: This cross-sectional study included 501 women working in the medical professions at Hamadan University of Medical Sciences in western Iran in 2018. The subjects were selected by stratified random sampling. Data were collected using a researcher-developed, self-report questionnaire that contained demographic information and questions based on protection motivation theory and social support theory. Descriptive data analysis was conducted using SPSS version 23 and model fitting with PLS version 2. RESULTS: The mean age of the participants was 37.1±8.3 years, and most of the women (80.4%) were married. Most women had a bachelor's degree (67.5%). The findings of this study showed that the coping appraisal construct was a predictor of protection motivation (β=0.380, p<0.05), and protection motivation (β=0.604, p<0.05) was a predictor of breast self-examination behavior. Additionally, social support theory (β=0.202, p<0.05) had a significant positive effect on breast self-examination behavior. CONCLUSIONS: The frequency of practicing self-examinations among women employees in the medical sector was low; considering the influence of social support as a factor promoting screening, it is necessary to pay attention to influential people in women's lives when designing educational interventions.
Breast Neoplasms
;
Breast Self-Examination
;
Breast
;
Cross-Sectional Studies
;
Delivery of Health Care
;
Early Diagnosis
;
Female
;
Humans
;
Iran
;
Mass Screening
;
Mortality
;
Motivation
;
Self-Examination
;
Statistics as Topic